ARCHIVES

Also in this 12-page issue: NCI gives Doroshow and Fine “lead role” in clinical trials system review.

This article is from The Cancer Letter archive.

Vol. 29 No. 42 | November 14, 2003

Download PDF Visit The Full Archive

Related Articles

NIH Director: NCI’s Special Authorities “More Of A Negative Than A Positive”

June 11, 2010

Loeb Named ACS President, Eyre President Elect

November 14, 1986

NCI, NIH Make Half-Hearted Pitch For Cancer Act Before Seemingly Uninterested Rogers Committee

March 10, 1978

NCI to Host SBIR Investor Forum

November 7, 2014

Senate Appropriators Plan Hearing On NCI Ouster Of Fisher

June 3, 1994

NCI Viewed As NIH’s ‘Administrative Reserve,” Broder Tells Directors

July 12, 1991